Annual Retained Earnings
-$1.12 B
-$145.22 M-14.96%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual retained earnings is -$1.12 billion, with the most recent change of -$145.22 million (-14.96%) on December 31, 2023.
- During the last 3 years, DNLI annual retained earnings has fallen by -$761.80 million (-214.94%).
- DNLI annual retained earnings is now -6520.47% below its all-time high of -$16.86 million, reached on December 31, 2015.
Performance
DNLI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.42 B
-$107.19 M-8.14%
September 30, 2024
Summary
- As of February 7, 2025, DNLI quarterly retained earnings is -$1.42 billion, with the most recent change of -$107.19 million (-8.14%) on September 30, 2024.
- Over the past year, DNLI quarterly retained earnings has dropped by -$107.19 million (-8.14%).
- DNLI quarterly retained earnings is now -1275.91% below its all-time high of -$103.51 million, reached on December 31, 2016.
Performance
DNLI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
DNLI Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.0% | -8.1% |
| 3 y3 years | -214.9% | -46.7% |
| 5 y5 years | -389.7% | -46.7% |
DNLI Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.1% | at low | -120.8% | at low |
| 5 y | 5-year | -214.9% | at low | -301.9% | at low |
| alltime | all time | -6520.5% | at low | -1275.9% | at low |
Denali Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.42 B(+8.1%) |
| Jun 2024 | - | -$1.32 B(+8.1%) |
| Mar 2024 | - | -$1.22 B(+9.1%) |
| Dec 2023 | -$1.12 B(+15.0%) | -$1.12 B(+12.0%) |
| Sep 2023 | - | -$996.74 M(+11.1%) |
| Jun 2023 | - | -$897.38 M(-17.0%) |
| Mar 2023 | - | -$1.08 B(+11.3%) |
| Dec 2022 | -$970.99 M(+50.5%) | -$970.99 M(+11.3%) |
| Sep 2022 | - | -$872.31 M(+13.4%) |
| Jun 2022 | - | -$769.01 M(+8.3%) |
| Mar 2022 | - | -$710.22 M(+10.1%) |
| Dec 2021 | -$645.00 M(+82.0%) | -$645.00 M(+13.2%) |
| Sep 2021 | - | -$569.74 M(+17.4%) |
| Jun 2021 | - | -$485.15 M(+14.3%) |
| Mar 2021 | - | -$424.46 M(+19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -$354.42 M(-16.7%) | -$354.42 M(-40.9%) |
| Sep 2020 | - | -$599.30 M(+10.8%) |
| Jun 2020 | - | -$541.07 M(+12.2%) |
| Mar 2020 | - | -$482.31 M(+13.3%) |
| Dec 2019 | -$425.55 M(+86.7%) | -$425.55 M(+14.5%) |
| Sep 2019 | - | -$371.53 M(+14.2%) |
| Jun 2019 | - | -$325.27 M(+21.9%) |
| Mar 2019 | - | -$266.93 M(+17.1%) |
| Dec 2018 | -$227.94 M(+18.9%) | -$227.94 M(-25.4%) |
| Sep 2018 | - | -$305.47 M(+13.1%) |
| Jun 2018 | - | -$270.10 M(+25.4%) |
| Mar 2018 | - | -$215.38 M(+12.4%) |
| Dec 2017 | -$191.70 M(+85.2%) | -$191.70 M(+13.6%) |
| Sep 2017 | - | -$168.81 M(+63.1%) |
| Dec 2016 | -$103.51 M(+514.0%) | -$103.51 M |
| Dec 2015 | -$16.86 M | - |
FAQ
- What is Denali Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Denali Therapeutics?
- What is Denali Therapeutics annual retained earnings year-on-year change?
- What is Denali Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Denali Therapeutics?
- What is Denali Therapeutics quarterly retained earnings year-on-year change?
What is Denali Therapeutics annual retained earnings?
The current annual retained earnings of DNLI is -$1.12 B
What is the all time high annual retained earnings for Denali Therapeutics?
Denali Therapeutics all-time high annual retained earnings is -$16.86 M
What is Denali Therapeutics annual retained earnings year-on-year change?
Over the past year, DNLI annual retained earnings has changed by -$145.22 M (-14.96%)
What is Denali Therapeutics quarterly retained earnings?
The current quarterly retained earnings of DNLI is -$1.42 B
What is the all time high quarterly retained earnings for Denali Therapeutics?
Denali Therapeutics all-time high quarterly retained earnings is -$103.51 M
What is Denali Therapeutics quarterly retained earnings year-on-year change?
Over the past year, DNLI quarterly retained earnings has changed by -$107.19 M (-8.14%)